Press Release
July 31, 2013

July 31, 2013 (Boca Raton, FL)

July 31, 2013 (Boca Raton, FL) - Hundreds of medical professionals will convene September 18-21, 2013 for Board Certification Exams, Fellowship Modules, and Bio-Identical Hormone Replacement Therapy Symposium.

The American Board of Anti-Aging and Regenerative Medicine (ABAARM) written and oral certification exams will be held during this event. Also, physicians have the opportunity to sit for The American Board of Anti-Aging Health Practitioners (ABAAHP) written exam as well.

The American Academy of Anti-Aging Medicine’s (A4M) Fellowship on Anti-Aging and Regenerative Medicine (FAARM) will host several modules including Module IV: Nutrition and Metabolism; Module VIII: Lab Fundamentals and Cancer Therapies; Module XVI (C): Cardiovascular; and The Fellowship in Integrative Cancer will host Module VII: Dietary Treatments of Cancer.

Some learning objectives for Module IV include learning about nutritional depletions caused by medications, nutrition’s role and impact on optimal health in aging patients, new treatment plans for osteoporosis and amino acid deficiencies, and how physical, psychological and spiritual health relate to metabolic and anti-aging medicine, among other lessons.

Module VIII attendees will learn advanced integrative approaches to cancer therapies, nutritional support for athletes, how nutrients affect psychiatric illness treatments, and new protocols for advanced stage cancers.

Module XVI (C) will teach its participants nutritional and dietary therapies for prevention and treatment of cardiovascular disease, as well as sex hormone balance and function in regards to cardiovascular health in men and women, and also how nutrition plays a role in cardiovascular disease.

Cancer Module VII includes a literature review concerning diets high in Omega-6 fatty acids and the immune system, and how fat cells produce estrogen, among other topics.

The Bio-Identical Hormone Replacement Therapy Symposium (BHRT) will feature several well-known and distinguished experts in the fields of Anti-Aging and Regenerative Medicine.

Some speakers and topics include Eric Braverman, MD covering the psychological effects of BHRT and how BHRT affects the brain. Jennifer Landa, MD, OB/GYN, FAARM, will discuss sexual dysfunction and estrogen, progesterone, and testosterone therapies in peri-menopause and menopausal women. Thierry Hertoghe, MD will explain reversing the aging process with BHRT and analyzing lab tests of complicated patients. Ronald Rothenberg, MD will discuss treating adult growth hormone deficiency and will lecture on Hyperthyroidism. Director of the Fellowship on Anti-Aging and Regenerative Medicine, Pam Smith, MD, MPH, MS, will kick off the weekend with an introduction to BHRT and how BHRT solves common female health problems. Lastly, Jonathan Wright, MD will explain women’s hormone replacement and adrenal fatigue, stress and cortisol.

About the American Academy of Anti-Aging Medicine

As a federally registered 501(c)3 non-profit organization, the American Academy of Anti-Aging Medicine (A4M) is the world's largest non-profit scientific society of physicians and scientists dedicated to the advancement of technology to detect, prevent, and treat aging related disease and to promote research into methods to retard and optimize the human aging process.

A4M offers exclusive membership to all medical professionals where they gain access to over two-decades of established medical expertise. We are also dedicated to educating physician and scientists and are proud to be in our 21st year of providing first-class continuing education conferences on anti-aging issues, regenerative and functional medicine.

To further demonstrate our commitment to the future of medicine, the shared responsibility for patient outcomes and transforming health education through innovation, we offer Board Certifications and Fellowship Training Programs in various disciplines ranging from anti-aging, regenerative and functional medicine to such disciplines as aesthetic medicine, skin cancer and stem cell therapy, in order to lead the industry by establishing best practice standards in these areas.